Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile Determination

During pharmacotherapy, knowledge about the actual drug and metabolite concentrations in plasma is often critical. Individual dose adjustments can be performed based on pre‐emptive genotyping of certain absorption, distribution, metabolism, and excretion (ADME) genes but also using therapeutic drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Pridgeon, Chris S., Johansson, Inger, Ingelman‐Sundberg, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795957/
https://www.ncbi.nlm.nih.gov/pubmed/35766115
http://dx.doi.org/10.1002/cpt.2695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795957/
https://www.ncbi.nlm.nih.gov/pubmed/35766115
http://dx.doi.org/10.1002/cpt.2695

Ejemplares similares